- Report
- March 2025
- 50 Pages
Spain
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
Italy
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
United Kingdom
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
Germany
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
France
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
Mexico
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
Canada
From €552EUR$600USD£470GBP
- Report
- March 2025
- 50 Pages
United States
From €552EUR$600USD£470GBP
- Report
- February 2025
- 236 Pages
United States
From €7349EUR$7,995USD£6,264GBP
- Report
- December 2024
- 34 Pages
Canada
From €4592EUR$4,995USD£3,913GBP
- Report
- December 2024
- 31 Pages
Australia
From €4592EUR$4,995USD£3,913GBP
- Report
- December 2024
- 30 Pages
India
From €4592EUR$4,995USD£3,913GBP
- Report
- December 2024
- 31 Pages
Germany
From €4592EUR$4,995USD£3,913GBP
- Report
- November 2024
- 750 Pages
Global
From €1838EUR$2,000USD£1,567GBP
- Report
- November 2024
- 750 Pages
Global
From €1838EUR$2,000USD£1,567GBP
- Report
- October 2024
- 216 Pages
Global
From €3677EUR$4,000USD£3,134GBP
- Report
- September 2024
- 117 Pages
Global
From €4137EUR$4,500USD£3,526GBP
- Report
- May 2024
- 142 Pages
Global
From €3677EUR$4,000USD£3,134GBP
- Report
- February 2024
- 158 Pages
Global
From €4274EUR$4,650USD£3,643GBP
- Report
- January 2024
- 315 Pages
Global
From €3217EUR$3,500USD£2,742GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more